Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes Mellitus

NCT00363844 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

209

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sitagliptin phosphate

Sponsor

Ono Pharmaceutical Co., Ltd.